Dr. Glynn Wilson - 19 Jan 2023 Form 3 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Director
Signature
/s/ GLYNN WILSON
Issuer symbol
CVKD
Transactions as of
19 Jan 2023
Net transactions value
$0
Form type
3
Filing time
19 Jan 2023, 19:29:20 UTC
Previous filing
30 Dec 2022
Next filing
24 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVKD Stock Options 19 Jan 2023 Common Stock 50,000 $5.00 Direct
holding CVKD Convertible Promissory Note 19 Jan 2023 Common Stock 50,000 $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Wilson is the holder of a convertible promissory note in the principal amount of $50,000 that is convertible into 50,000 shares of common stock issuable upon consummation of the initial public offering of Cadrenal Therapeutics, Inc., based on an as adjusted conversion price of $1.00 per share.